Phase 3 Study of Pexidartinib for Pigmented Villonodular Synovitis (PVNS) or Giant Cell Tumor of the Tendon Sheath (GCT-TS)

Chris O'Brien Lifehouse, Sydney

Herlev Hospital, Herlev

Peter MacCallum Cancer Centre, East Melbourne

Princess Alexandra Hospital, Woolloongabba

Memorial Sloan Kettering Cancer Center, New York

HELIOS Klinikum Berlin-Buch, Berlin

Istituto Nazionale Tumori-Fondazione IRCCS, Milan

Duke Cancer Center, Durham

Mayo Clinic Cancer Center, Jacksonville

Sylvester Comprehensive Cancer Center, Miami

Moffitt Cancer Center, Tampa

Vanderbilt-Ingram Cancer Center, Nashville

Istituto Ortopedico Rizzoli, Bologna

Hospital Universitario Virgen del Rocío, Seville

Universitätsklinikum Essen, Essen

Michigan Comprehensive Cancer Center, Ann Arbor

Mayo Clinic Cancer Center, Rochester

Washington University School of Medicine, St Louis

Centre Leon Bérard, Lyon

Huntsman Cancer Institute, Salt Lake City

University of Southern California, Los Angeles

UCLA Medical Center, Santa Monica

Stanford Cancer Center, Palo Alto

Institut Gustave Roussy, Villejuif

OHSU Knight Cancer Institute, Portland

Seattle Cancer Care Alliance, Seattle

Mayo Clinic, Scottsdale

Massachusetts General Hospital, Boston

: Dana Farber Cancer Institute, Boston

MD Anderson Cancer Center at Cooper, Camden

Princess Margaret Hospital, Toronto

McGill University Health Centre, Montreal

Military Hospital-State Health Center, Budapest

Leiden University Medical Center, Leiden

Radboud Univ. Medical Center, Nijmegen

Centrum Onkologii-Instytut im. Marii Skłodowskiej-Curie, Warsaw

Hospital de la Santa Creu i Sant Pau, Barcelona

University College Hospital, London

The Royal Marsden NHS Foundation Trust, London